The surgery was done for a college-aged athlete who had chronic pain from a previous meniscectomy, according to a Feb. 6 news release. RejuvaKnee, developed by Regenity Biosciences, has FDA clearance and has been shown to support a more complete recovery by facilitating regeneration of native meniscus tissue.
Dr. Fleissner plans to perform more meniscus repairs with the implant, the release said.